Andrea Renninger

Andrea Renninger currently serves as Senior Director of Regulatory Affairs for Companion Diagnostics at Daiichi Sankyo, Inc., a position held since July 2023. Previous experience includes a successful tenure at Bristol Myers Squibb from March 2014 to June 2023, where Andrea held the roles of Senior Director in Global Regulatory Strategy for Precision Medicine & Digital Health, as well as Director and Global Regulatory Lead in Precision Medicine. Earlier experiences also encompass senior management roles at Eisai Pharmaceuticals and Schering Plough Corporation, alongside foundational roles at Becton Dickinson and Temple University. Educational qualifications include a BS in Biology from Kutztown University of Pennsylvania and advanced study at Temple University.